Justice Department eases restrictions on some marijuana products
Quick Insights
The Bottom Line
The Justice Department eased restrictions on some marijuana products by lowering their classification.
How This Affects You
This order could increase access to FDA-approved and state-regulated medical marijuana products.
AI Summary
The Justice Department has eased restrictions on certain marijuana products, reclassifying them to a lower drug classification. This order specifically applies to FDA-approved products containing marijuana and state-regulated medical marijuana products. This move could significantly alter how these specific cannabis products are regulated at the federal level. It represents a shift in federal drug policy regarding certain marijuana-derived substances and medical cannabis.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump signed an executive order to accelerate research and review of psychedelic drugs like psilocybin and ibogaine for mental health treatments. This move aims to fast-track their potential medical applications, with figures like Joe Rogan joining the announcement.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order aimed at accelerating the federal review process for psychedelics. The order seeks to expand access to psychedelic drug treatments for mental health, specifically mentioning substances like ibogaine, LSD, and psilocybin.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelic Drug Initiative
President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.
Trump Administration's Push for Psychedelic Drug Treatments
President Donald Trump has signed an executive order to accelerate access to and research into psychedelic drug treatments. This move aims to expand the availability of substances like LSD, psilocybin, and ibogaine for mental health treatment and research.
Trump Administration's Reclassification of Marijuana
The Trump administration has reclassified state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move that significantly eases restrictions and could impact future legalization efforts.
Trump Administration Reclassifies Marijuana
The Trump administration has reclassified state-licensed medical marijuana as a 'less-dangerous drug,' moving it from Schedule I to Schedule III under the Controlled Substances Act. This significant policy shift is expected to ease research barriers and impact the growing cannabis industry.
Civil Rights & Justice
Following developments in civil rights, criminal justice reform, voting rights, Supreme Court decisions, policing accountability, and the ongoing struggle for equality and justice across American institutions.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
Government TransparencyIn reversal, Justice Department withdraws subpoenas in John Brennan investigation, AP sources say - AP News
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSUFNVmFFRGluOUdENTFrRmxFMGFNTU10SERWeTdzLW93N19PbERCYW1PUkhMTXNsQ2c4SVhpS3ZaaWp4VmlLTlVJaGQtbHVsY1RJaFl2SUl0cTctY2J4aXEwWE1ZZnF6RkxvWEE2UVlTaUJNaUFwZkFZQ04tMVpLZmpyc0VITGRQRElQZVE5bE51MWM0VW8wb0JxLTFyNXdwNmZNTFJ4RGNNZ2VweFh5bVl6Nm1MejJf?oc=5" target="_blank">In reversal, Justice Department withdraws subpoenas in John Brennan investigation, AP sources say</a> <font color="#6f6f6f">AP News</font>
Government TransparencyFears of looser standards as the FBI and Justice Department scramble to fill a depleted workforce - AP News
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQWkFYYlM2RXpvRDRrc3ZlN0M2RkVDVjNkbkNCZFJhdnVDbXduQkdXQzFmZi1MQ2Z6R1g0OHFjNmVYSWVDT055bXEydnhaeUFUN3pfLWNVUk11WDI5R1pvQ1o1aDFQMTE5Qm1ETnFER1Z1RHhHWEJvcjdjbjVnMWhxMExyb3h1VDNENkoxYVNfUVBPNEtDVGVtMTA5S0lwc2NJQ3oyRU4xaDloZ3lXTWxzazBPRVdGUFcxczhHaA?oc=5" target="_blank">Fears of looser standards as the FBI and Justice Department scramble to fill a depleted workforce</a> <font color="#6f6f6f">AP News</font>
PoliticsDepartment of Justice investigating Eric Swalwell amid sexual assault allegations
<p>Democratic representative from California has suspended gubernatorial campaign and resigned from Congress</p><p>The US Department of Justice (DoJ) has opened an investigation into Eric Swalwell following his resignation from Congress, according to a source familiar with the matter.</p><p>The news of a federal investigation comes days after the Democratic representative from California <a href="https://www.theguardian.com/us-news/2026/apr/14/eric-swalwell-tony-gonzales-resignations">stepped down</a> due to multiple allegations of sexual misconduct.</p> <a href="https://www.theguardian.com/us-news/2026/apr/16/eric-swalwell-department-of-justice-investigation">Continue reading...</a>
PoliticsUS Justice Department adds former Trump lawyer to probe of former CIA director, CNN reports - Reuters
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOS0lJQmdXVG1hU2cxdVB6eElqYUpVcXR5WURXdE13V1hON1ZOSkxaTmJVc1ZER0QtNkhCM1lrelJMZWEyd3VaVUxuV3hVZUFvYlBRRVdnUGpJWFNFYmJLVmNmak5Oem1iQVVVTnNnYUYwbDlQcTNFUHU1cmtaTlBfbEo4VlpyLXhqOTNTbXI2N04yanFPdGhwd3hraHVtMTFuSkNFVUVhcmhsVjhwMFZWTjR4LWVCRFpnTm50bkcxSlZteVhNOTVObXVkTms?oc=5" target="_blank">US Justice Department adds former Trump lawyer to probe of former CIA director, CNN reports</a> <font color="#6f6f6f">Reuters</font>
PoliticsScoop: Trump set to reclassify marijuana soon
<p>The <a href="https://www.axios.com/politics-policy/donald-trump" target="_blank">Trump</a> administration is expected to move to <a href="https://www.axios.com/2025/12/18/trump-reclassify-marijuana-weed-schedule-drugs" target="_blank">reclassify</a> marijuana as soon as Wednesday, per an administration official familiar with the matter.</p><p><strong>Why it matters: </strong>The move would make it easier to study medicinal applications of marijuana and could shore up support from <a href="https://www.axios.com/2026/04/20/trump-woos-rogan-after-split" target="_blank">influencers</a> who support the research.</p><hr><ul><li>The move follows an executive order from the president last year to reclassify marijuana as a Schedule III drug, which is a years-long process. </li></ul><p><strong>How it works: </strong><a href="https://www.axios.com/2025/12/12/trump-marijuana-federal-restrictions-reclassify" target="_blank">Reclassifying</a> marijuana eases U.S. Drug Enforcement Administratio...
Government TransparencyWho owns presidential records? Trump's Justice Department says it's him
The Trump administration asserts a nearly 50-year-old law requiring the preservation of presidential records is unconstitutional. Historians warn important papers could be destroyed.
Justice Department charges Southern Poverty Law Center with fraud over extremism investigations
The Justice Department on Tuesday announced fraud charges against the Southern Poverty Law Center over its nonprofit investigations into extremist groups. CBS News justice reporter Jake Rosen has the details.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Trump-branded data center project CEO departs
6 crew still missing after overturned ship that disappeared after typhoon is found near Saipan - AP News
US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules
